Clofarabine-based salvage chemotherapy for relapsed or refractory acute leukemia before allogeneic stem cell transplantation: results from a case series
- 2 November 2009
- journal article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 50 (12) , 2071-2074
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Allo-SCT conditioning for myelodysplastic syndrome and acute myeloid leukemia with clofarabine, cytarabine and ATGBone Marrow Transplantation, 2009
- Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphomaLeukemia & Lymphoma, 2009
- A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndromeBlood, 2008
- The Combination of Clofarabine and Cytarabine in Pediatric Relapsed Acute Lymphoblastic Leukemia: A Case ReportChemotherapy, 2008
- Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemiaBlood, 2003
- The Treatment of Acute Myeloid Leukemia in First Relapse: A Comprehensive Review of the LiteratureLeukemia & Lymphoma, 2002
- Treatment of relapsed and refractory acute myelogenous leukemiaLeukemia, 2000
- Neurotoxicity of purine analogs: a review.Journal of Clinical Oncology, 1994